Accurate Non-parametric Estimation of Recent Effective Population Size from Segments of Identity by Descent  by Browning, Sharon R. & Browning, Brian L.
ARTICLE
Accurate Non-parametric Estimation
of Recent Effective Population Size
from Segments of Identity by Descent
Sharon R. Browning1,* and Brian L. Browning2
Existing methods for estimating historical effective population size from genetic data have been unable to accurately estimate effective
population size during the most recent past. We present a non-parametric method for accurately estimating recent effective population
size by using inferred long segments of identity by descent (IBD). We found that inferred segments of IBD contain information about
effective population size from around 4 generations to around 50 generations ago for SNP array data and to over 200 generations ago
for sequence data. In human populations that we examined, the estimates of effective size were approximately one-third of the census
size. We estimate the effective population size of European-ancestry individuals in the UK four generations ago to be eight million and
the effective population size of Finland four generations ago to be 0.7 million. Our method is implemented in the open-source IBDNe
software package.Introduction
The effective size of a population is defined with reference
to an idealized randommating population that has similar
random changes in allele frequencies over time to those
occurring in the actual population. The effective size of
the actual population is defined as the number of individ-
uals in that idealized population.1 Because of its effect on
genetic drift, the effective population size affects the speed
and effectiveness of selective forces.2 In small populations,
variants subject to weak negative selection have a non-
negligible probability of drifting to high frequencies. This
is why populations with a small historical effective popula-
tion size, such as Finland,3 play an important role in the
discovery of genetic variants that influence disease risk.
In addition, estimates of historical effective population
size reveal important demographic features, such as bottle-
neck events and rates of growth.4,5
Demographic arguments suggest that in modern human
populations, the effective size should be around one-third
of the census size.6 However, existing genetics-based esti-
mates are much lower. For example, a recent analysis of
the site frequency spectrum (SFS) from sequence data on
over 10,000 European-American individuals gave a current
estimated effective population size of 1.1 million,5,7 which
is 0.5% of the census figure of 224million white Americans
(2010 US census; see Web Resources).
The SFS is an important tool for estimating effective pop-
ulation size, but several problematic issues surround its
use. One issue is that it is difficult to make highly accurate
genotype calls for alleles of very low frequency, especially
in low-coverage sequence data, and this results in both
false-negative and false-positive rare-variant calls. One
way to get around this problem is to account for uncer-
tainty when constructing the SFS,8,9 although doing so re-1Department of Biostatistics, University of Washington, Seattle, WA 98195, U
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difficult to quantify. A second issue is that very large sam-
ples of sequenced individuals are required for accurately
estimating recent population size from the SFS.5
Information in genetic data about effective population
size comes from historical mutation events and also from
historical recombination events. Approaches based on
the ancestral recombination graph (ARG), such as the pair-
wise sequentially Markovian coalescent method,10 make
use of both sources of information. However, because of
computational constraints, they are limited to analysis of
a small number of individuals,10 which restricts their abil-
ity to make inferences about the very recent past.10 A
recently proposed method increases the number of haplo-
types that can be analyzed to eight, allowing estimation of
effective population size to extend up to 2,000 years, or
approximately 70 generations, ago.11
Many methods for inferring the history of effective pop-
ulation size, including those that use the SFS, take a para-
metric approach.12 In a parametric approach, a class of
models, parameterized, for example, by a recent growth
rate and a time of commencement of growth, is considered
across a grid of values for the parameters. Each such model
is considered in turn, and the best-fit model is found. Un-
certainty in the model fit can be addressed only with
respect to the models that are considered. It is difficult to
model complex or unanticipated features of population-
size history with parametric methods because the user
must pre-specify the class of models that are considered,
and computational and statistical constraints limit the
number of parameters that can be considered. For
example, it is difficult to fully capture super-exponential
growth with parametric methods.
Some parametric methods for inferring effective popula-
tion size primarily use the information generated bySA; 2Division of Medical Genetics, Department of Medicine, University of
y of Human Genetics. All rights reserved.
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historical recombination. These methods typically make
use of the length of genomic segments that two individuals
have inherited without recombination (identical by
descent) from a common ancestor. Harris and Nielsen
used sharing of identical-by-state haplotypes of length
greater than 100 bp to estimate demographic history.13
Palamara et al. used inferred identity-by-descent (IBD) seg-
ments of length greater than 1 cM to estimate recent effec-
tive population size.4 Harris and Nielsen fit a piecewise
constant effective population size, such that the fitted
model for Europeans had size 13,000 for the past 6,000
years. Palamara et al. fit two periods of exponential growth
or contraction separated by a founder event to their Ashke-
nazi Jewish data by using historical reports as well as model
goodness of fit to guide their choice of model form.
In this study, we took a non-parametric approach and
used inferred IBD segments with a length larger than a
threshold. The threshold had to be large enough so that
IBD segments were inferred with high power and a low
false-positive rate. Consequently, the utilized IBD seg-
ments were relatively long and reflected recent demo-
graphic history. Thus, our method is designed to estimate
recent effective population size. It cannot estimate ancient
population size.
Our method is related to that of Palamara et al. in that it
uses inferred IBD segments and relies on calculations based
on theWright-Fisher discrete-generationmodel.1 However,
the methods differ in the distributions that are estimated.
Palamara et al. calculate the expected distribution of IBD-
segment lengths given a parametrized demographicmodel.
Our method calculates the expected distribution of the
time to themost recent common ancestor (TMRCA) in gen-
erations, given an IBD-segment length. It uses the quantity
of IBD assigned to each TMRCA to estimate the effective
population size for that TMRCA. This fast and flexible
approach frees our method from parametric constraints.
Our method is also related to Ralph and Coop’s
method for estimating the age of IBD segments.14 Like
Ralph and Coop, we fit a non-parametric model. Howev-
er, our generalized expectation-maximization (EM) proce-
dure for fitting the trajectory of the historical population
size is very different from Ralph and Coop’s use of nu-
merical optimization and penalized likelihoods to fit
the coalescence-time distribution. Ralph and Coop do
not directly estimate effective population size, but effec-
tive sizes can be obtained from their estimated coalescent
rates.Material and Methods
Overview of Estimation Procedure
We consider only detected IBD segments with an inferred genetic
length (measured in cM) larger than a threshold.
We use an iterative, generalized EM algorithm.15 Our iterative
approach is in the spirit of a standard EM approach, such that it
has alternating steps that predict missing data and estimate
parameters given the predicted complete data. However, ourThe Americanapproach uses method-of-moments estimation rather than
maximum-likelihood estimation. At each iteration, we start with
a current estimate of the historical diploid effective population
size,N ¼ {N[g]; g ¼ 0, 1, 2,.}, where g indexes the number of gen-
erations before the present. Initial values for N are generated with
an auto-regressive model. We use the current estimate of N to es-
timate the observed and expected amounts of IBD due to the
most recent common ancestors g generations before the present.
We then fit a piecewise exponential growth function to the
observed and expected amounts of IBD due to each generation
to obtain an updated estimate of historical effective population
size N.
We iterate this process of updating the estimate of N until
convergence. We have found that 50 iterations are sufficient
(data not shown). We repeat this iterative procedure by usingmul-
tiple random initial values for the historical effective population
size and then average the resulting estimated population sizes at
each generation.We estimate confidence intervals for the effective
population size at each generation from bootstrap samples.
The details of our estimation procedures are described below
and in Appendix A.Detecting IBD Segments
We used IBDseq16 version r1206 with default settings to infer IBD
segments from real and simulated sequence and SNP array data.
We used IBDseq rather than haplotype-based methods such as
GERMLINE17 or RefinedIBD18 because switch errors in estimated
haplotypes can cause haplotype-based methods to erroneously
break long IBD segments into shorter sub-segments.Filtering IBD Segments
We first applied a length filter that excluded IBD segments that
were shorter than a threshold (typically 2 cM for sequence data
and 4 cM for SNP array data). We used the HapMap recombination
map19 to determine genetic distances in the non-simulated data.
We then excluded genomic regions that had highly elevated levels
of detected IBD. The excluded regions differed somewhat from one
dataset to another, but they generally included some centromeres
and telomeres, the major histocompatibility complex on chromo-
some 6, and the large chromosome 8 inversion. The excess IBD
might be due to extended linkage disequilibrium in these regions.
To identify regions with highly elevated levels of detected IBD, we
first calculated the 3%-trimmed mean and 3%-trimmed SD for the
number of IBD segments at 0.25 cM intervals in the genome. We
then excluded genomic regions for which the number of IBD seg-
ments at a locus was more than 10 trimmed SDs from the trimmed
mean. After excluding genomic regions with extreme amounts of
IBD, we analyzed each remaining continuous chromosome inter-
val as if it were a separate chromosome. We excluded any chromo-
some intervals that had a length less than 50 cM because inclusion
of very short chromosome intervals in the bootstrap sampling
could lead to higher bootstrap variability. For simplicity, we refer
to each retained continuous chromosome interval as a chromo-
some in the following discussion.Trimming Chromosome Ends
In themethodology described in Appendix A, wemust account for
whether an IBD segment reaches either end of the chromosome.
For inferred IBD, it is not always clear whether the true underlying
segment reaches the end of the chromosome. For example, the in-
ferred IBD segment might end 1 kb from the end of theJournal of Human Genetics 97, 404–418, September 3, 2015 405
chromosome, whereas the true IBDmight extend to the end of the
chromosome. In comparing true and inferred IBD segments for
simulated data, we found that when the true segment reached
the end of the chromosome, the inferred segment almost always
reached within 0.2 cM of the end of the chromosome. We thus
trimmed 0.2 cM from each end of the chromosome after inferring
IBD and removing regions with excess IBD. This reduced the total
chromosome length and the lengths of some of the IBD segments.
For example, an inferred segment starting at 0.1 cM started at
0.2 cM after trimming. We discarded any segments that were
shorter than the threshold for IBD-segment length after trimming.Removing Close Relatives
Full siblings create a problem for the analyses presented here
because the IBDseq method that we used for detecting IBD as-
sumes that individuals share zero or one identical-by-descent
haplotype, and it does not consider the possibility that individuals
share two pairs of haplotypes that are identical by descent, as
occurs in full siblings. Hence, we chose to remove full siblings
from the analysis. Full siblings have TMRCA ¼ 1 for segments
shared identically by descent through one of their parents, as do
half siblings, so we removed all half siblings and closer relatives,
and we did not directly estimate N[1]. Therefore, we estimated
N[g] for gR g*, where g* ¼ 2, and we extrapolated the exponential
growth rate between N[3] and N[2] to estimate N[1] and N[0].
We can detect pairs of related individuals by using whole-
genome rates of IBD-segment sharing.20 In half siblings, the ex-
pected proportion of the genome covered by an IBD segment is
0.5, and there is variation around that value. We set the threshold
of the IBD proportion at 0.4 and excluded all IBD segments for a
pair of individuals if the sum of their IBD segment lengths ex-
ceeded this proportion of the genome. This filtering removed
half siblings and closer relatives (full siblings and parent-offspring
pairs). It also removed avuncular pairs (TMRCA¼ 1.5) but retained
more-distant relative pairs.Initial Values for N
We refer to the sequence of historical effective population sizes,
N ¼ {N[g]; g ¼ 0, 1, 2, .}, as a trajectory. We simulated the log
of the initial trajectory as an autoregressive model of order 1.
This is the discrete time analog of an Ornstein-Uhlenbeck process
and has the properties of being stationary and Markovian. We
worked on the log scale because the effective population size is
constrained below by 0. Because the effective population size in
humans at the time of migration out of Africa is estimated to be
approximately 10,000, our autoregressive process has a mean of
log(N[g]) equal to m ¼ log(10,000) and a SD of log(N[g]) equal to
s ¼ log(10,000)/10, which allows some variation around this
mean, but not excessive levels. The parameter d controls the de-
gree of correlation between successive values, and we used d ¼
0.02. Given the value of log(N[g  1]), the value of log(N[g]) is
(1  d)log(N [g  1]) þ Y, where Y is normally distributed with
mean dm and SD
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1 ð1 dÞ2
q
s. This ensures that log(N[g]) also
has a normal distribution with mean m and SD s.Updating Estimates of N
We used the current estimate ofN to estimate the observed and ex-
pected amounts of IBD due to the most recent common ancestors
that are g generations before the present. We then fit a piecewise
exponential growth function to these values to obtain an updated406 The American Journal of Human Genetics 97, 404–418, Septembestimate of N. Complete mathematical details are presented in
Appendix A.Averaging Results from Multiple Random Starts
Averaging results from multiple random initial trajectories yields
smoother and more accurate final estimates. We randomly gener-
ated 50 initial trajectories, and we used a harmonic mean to
average the results. That is, if initial trajectory i has estimatesbNi½g, the final estimate is
bN ½g ¼ 50X50
i¼1
1
 bNi½g:
We used a harmonic mean because bNi½g is inversely proportional
to the amount of observed IBD that is assigned to generation g.Bootstrapping to Assess Uncertainty
We bootstrapped over chromosomes in order to assess precision of
the estimated effective population sizes. For each bootstrap itera-
tion, we resampled chromosomes with replacement. For each
bootstrap iteration, we repeated the iterative process of estimating
effective population sizes, including using 50 random initial tra-
jectories. We performed 80 bootstrap replicates and used the
2.5th and 97.5th percentiles of the bootstrap values at each gener-
ation to obtain 95% confidence intervals.Software
We implemented the above methods in a documented, open-
source Java program called IBDNe (seeWeb Resources). The IBDNe
program reads in IBD segments detected with the IBDseq program,
filters IBD segments and genomic regions as described above, and
reports an estimate and 95% confidence interval for the effective
population size at generations g ¼ 0, 1, 2, 3, ., G before the pre-
sent generation, where G is a user-specified maximum number
of generations. The software is parallelized to optimize computing
times. Computing times for IBDNe are presented in the Results
and were obtained on a 12-core 2.6 GHz computer with Intel
Xeon E5-2630v2 processors running Red Hat Enterprise Linux
release 6.6. For most datasets, computing times were approxi-
mately 30 min. These computing times did not include the time
to run IBDseq to find the IBD segments.Results
Simulated Data
We used simulated data to assess the number of past gener-
ations that can be accurately estimated from data with
different marker densities and population histories.
We simulated three scenarios. In the first (‘‘constant
size’’), the population had a constant size of 10,000. In
the second (‘‘exponential growth’’), the population size
was 10,000 until 150 generations ago and then grew at a
rate of 3.07% per generation to a current size of
1,000,000. In the third (‘‘super-exponential’’), the popula-
tion size was 10,000 until 100 generations ago and then
grew at an increasing rate: 0.1% from generations 100 to
99, 0.2% from generations 99 to 98, 0.3% from generations
98 to 97, and so on. With this super-exponential growther 3, 2015
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Figure 1. Estimating Effective Population Size by Using IBD Segments Inferred from Simulated Sequence Data by IBDseq
The threshold on inferred IBD length is 2 cM. Each plot shows a different simulation scenario (constant size, exponential growth, or
super-exponential growth). The blue dashed line in each plot shows the true effective population size, the black line is the estimated
effective population size, and the gray regions are bootstrap 95% confidence intervals. The y axes (effective population size) are plotted
on a log scale.rate, the population size g generations before the present is
N ¼ 10,000 3 exp((101  g)(100  g)/2,000).
In all three scenarios, the mutation and recombination
rates were 108 per bp, the genome size was 30 chromo-
somes of 100 Mb each (to approximate the total length
of the human genome), and 1,000 diploid individuals
were simulated. We used a coalescent-based simulator,
MaCS21 version 0.5d, to generate the data; the MaCS com-
mand-line arguments are given in Table S1. We analyzed
the output coalescent trees by using the DendroPy li-
brary22 to determine actual IBD status, interrogating the
trees every 10 kb, and looking for segments over which
the TMRCA remained constant for at least some minimum
distance (2–4 cM for most of the experiments reported
here).
We performed two sets of analyses, one with actual IBD
segments and one with inferred IBD segments. Because the
data are simulated under a coalescent model, the TMRCAs
of the IBD segments can take fractional values. We verified
that the expected rates of IBD are very similar between the
Wright-Fisher model with TMRCA ¼ g and the coalescent
model with TMRCA between g  0.5 and g þ 0.5 (data
not shown). When analyzing true IBD segments, we
removed IBD segments with TMRCA less than 1.5 genera-
tions ago to match the removal of half siblings and closer
relatives in the real data. When analyzing inferred IBD seg-
ments, we removed segments that overlapped a true IBD
segment with TMRCA less than 1.5 generations ago.
We analyzed simulated SNP array and sequence data.
The sequence data included all polymorphic variants. We
obtained the SNP data by removing variants with a fre-
quency less than 5%, and then we randomly selected
and removed 90% of the remaining variants. This gave a
final density of around 350,000 SNPs genome-wide in
each scenario.
Figure 1 shows results for IBD inferred from simulated
sequence data. We used a threshold of 2 cM because
IBDseq has high power and precision for segments of
length R 2 cM in sequence data.16 (Other length thresh-
olds are shown in Figure S1.) The lengths of the inferredThe AmericanIBD segments were almost unbiased (the mean difference
between true and inferred IBD lengths was 0.06 cM), and
the mean absolute difference between true and inferred
IBD lengths for actual segments of length > 2 cM was
0.15 cM. Only 0.5% of the actual segments of length
2–2.1 cM were not found by IBDseq. The estimates of the
effective population size from inferred IBD segments
were similar to those obtained from the true IBD segments
(Figure S2). Results for single random starts are shown in
Figure S3 and demonstrate the need to average over multi-
ple random starts to obtain more precise estimates.
Figure 2 shows results for inferred IBD from moderate-
density SNP data (350,000 SNPs genome-wide). Although
IBDseq was designed for sequence data, we have found
that it works quite well for SNP data in this context, pro-
vided that a sufficiently high IBD-length threshold is
used. We used a threshold of 4 cM here. (Results for other
thresholds are shown in Figure S4.) The lengths of the in-
ferred IBD segments were almost unbiased (the mean dif-
ference between true and inferred IBD lengths was
0.02 cM), but the mean absolute difference between true
and inferred IBD lengths for true IBD segments of length
at least 4 cM was 0.28 cM, which is twice as high as for
the sequence data. Only 0.8% of actual IBD segments of
length 4–4.1 cM were not found by IBDseq. With the
SNP data, there was some underestimation of effective
population size, particularly for the more distant past
(>50 generations ago). There were more true short seg-
ments than long ones, so added variability in length esti-
mation resulted in more inferred segments passing the
length threshold. In the growing population, the number
of inferred segments of length at least 4 cM was 14%
higher than the number of actual segments passing this
threshold. This excess in inferred number of IBD segments
resulted in underestimates of population size.
Overall, the estimates track the true historical popula-
tion sizes quite well, with two exceptions. First, if the pop-
ulation-size trajectory takes a sharp turn, the estimated
trajectory over-smooths and misses the corner. The IBD
segments cannot localize large changes in populationJournal of Human Genetics 97, 404–418, September 3, 2015 407
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Figure 2. Estimating Effective Population Size by Using IBD Segments Inferred from Simulated SNP Array Data by IBDseq
The threshold on inferred IBD length is 4 cM. The blue dashed line in each plot shows the true effective population size, the black line is
the estimated effective population size, and the gray regions are bootstrap 95% confidence intervals. The y axes (effective population
size) are plotted on a log scale.size to a single generation. Second, in some cases, the esti-
mated effective size oscillates somewhat around the true
value. This is particularly evident in some scenarios with
smaller sample sizes, such as 100 individuals (Figure S5).
In most cases, the true effective size is contained within
the bootstrap confidence interval; however, inferring
changes in growth rates could be dangerous because such
changes could reflect artifactual oscillation. The oscillation
can occur when the information contained in the IBD seg-
ments cannot distinguish between an oscillating and
smooth pattern of population change within a small win-
dow of generations. The issue of oscillation in the related
context of estimating the distribution of coalescent times
has been noted previously.14 Our strategy of fitting expo-
nential growth curves to small windows of generations re-
duces the oscillation problem considerably, but its effects
are still seen at low levels under some scenarios.
We also applied DoRIS (version 0.1.20130318), the soft-
ware implementing the parametric method of Palamara
et al.,4 with the actual IBD segments from the simulated
data (Figure S6). We considered the two relevant inbuilt
one-population models, which are constant size followed
by a single expansion (exponential growth) and constant
size followed by two periods of expansion with different
growth rates. For each scenario, we chose parameter-value
ranges that would allow the closest fit to the true values.
Not surprisingly, DoRIS estimates effective sizes for the
constant size and exponential growth scenarios very well.
For the super-exponential scenario, the single expansion
model fit as well as possible given the single growth rate.
The fit was slightly worse than that of our approach on
the same data: DoRIS estimated the current size to be
1 million and the ancestral size to be 16,500 (the true
current size is 1.56 million, and the true ancestral size is
10,000), and our method estimated the current size to be
1.47million (95% confidence interval¼ 1.01–2.20million)
and the average ancestral size over generations 100–200 to
be 8,900 (average 95% confidence interval ¼ 7,200–
10,800). DoRIS’s fitted double-expansion model had a
significantly worse fit than its single-expansion model408 The American Journal of Human Genetics 97, 404–418, Septembgiven that with five parameters rather than three, it was
necessary to use a coarser grid of parameter values (see
the Figure S6 legend for details).
DoRIS calculates a likelihood for each possible combina-
tion of the considered parameter values. For complex
models, this leads to high computation times. We consid-
ered a grid of 30–40 values for each of the three parameters
for DoRIS’s expansionmodel, resulting in 48,000 combina-
tions, and computing times of 3–8 hr depending on the
simulation scenario. All computation times are from a
2.6 GHz computer. For the five-parameter double-expan-
sion model, we had to restrict attention to 10–11 values
for each parameter, resulting in 110,000 combinations
and computing times of 14–35 hr. Clearly, much more
complex models are not computationally feasible with
the current implementation of DoRIS. For example, in
order to fit a different growth rate every eight generations
(as we do with our method) for the past 200 generations,
we would need 26 parameters, and even if we only
considered five values for each (which is unlikely to be
sufficient), we would need to consider over 1018 com-
binations. In contrast, fitting this model with an essen-
tially unlimited number of possible values for each
parameter took 13 min on a single computing core with
our IBDNe software (without bootstrap replicates). When
we included 80 bootstrap replicates to obtain confidence
intervals, the computing time was 30 min on a 12-core
computer.
Finland
We analyzed two Finnish datasets. The population of
Finland has relatively low genetic diversity, attributable
to a population bottleneck and isolation.3 Between 1750
and 1960, the population grew at an average annual rate
of 1.13%, increasing its population 10-fold from 420,000
to 4.4 million over this period. After 1960, growth slowed
somewhat, such that the population reached 5.5million in
2013, representing an average growth rate of 0.39% per
year since 1960 (census figures are from Statistics Finland;
see Web Resources).er 3, 2015
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Figure 3. Effective Population Size of
Finland and Northern Finland
The left panel shows estimated effective
sizes for the Finnish ALS cohort (black
line) and the Northern Finnish NFBC
(blue line). The threshold on inferred IBD
length is 6 cM in both cases. Bootstrap
95% confidence intervals are shown as
shaded regions (gray for ALS and blue for
NFBC). The y axis is plotted on a log scale.
Because the data are SNP data, only gener-
ations 0–50 are shown. The right panel
shows the ratio of estimated effective size
to census size (open circle) and bootstrap
95% confidence intervals (vertical lines).
The effective sizes are from the ALS anal-
ysis, and the census sizes are for Finland
for the years shown under the x axis.Northern Finland was sparsely populated until 300–
500 years (10–17 generations) ago,23 when migrants
from elsewhere in Finland moved into the region, and
population growth rates throughout Finland increased
dramatically.3
The first Finnish dataset represents Finland as a whole
and comprises 401 individuals diagnosed with amyotro-
phic lateral sclerosis (ALS [MIM: 105400; dbGaP:
acphs000344.v1.p1]). The DNA for this study was collected
between 1994 and 2008 from individuals who attended an
ALS specialty clinic that receives referrals from neurologists
throughout Finland.24 The average age of these individuals
was 57 years.24 The genotypes were generated with Illu-
mina SNP arrays. After we removed SNPs with more than
2% missing data, less than 1% minor allele frequency, or
a Hardy-Weinberg equilibrium p value less than 104,
314,000 autosomal SNPs remained for analysis.
The second Finnish dataset is the 1966 Northern Finland
Birth Cohort (NFBC) (dbGaP: phs000276.v1.p1). These ge-
notype data are from 5,402 individuals whose mothers
were living in the two northernmost provinces of Finland
(Oulu and Lapland) and had expected delivery dates in
1966. The individuals were genotyped with an Ilumina
HumanCNV370 array. We removed variants with a minor
allele frequency< 2%, missing proportion> 2%, or Hardy-
Weinberg p value < 105.
We used an IBD-length threshold of 6 cM. Estimated
effective population sizes were similar with a 5 or 7 cM
threshold, whereas results for a threshold of 4 cM had
higher estimated population sizes for >30 generations in
the past, indicating incomplete power to detect 4 cM seg-
ments (data not shown). Computing times were 11 min
for ALS and 34 min for NFBC.
The left panel of Figure 3 shows the estimated history of
the effective population sizes for the two samples. The esti-
mated effective sizes (3,000) for both samples are similar
for generations 30–50. The estimated effective size for the
NFBC hovered around 3,000 until approximately 15 gener-
ations ago, at which point it began to grow at increasing
rates. In contrast, growth of the estimated effective size
began much earlier for the ALS sample. This difference isThe Americanconsistent with the late settlement of Northern Finland,
whereby settlers came primarily from certain regions of
Finland and thus had a smaller effective size than Finland
as a whole at the time of settlement.
The ALS sample might represent a somewhat random
sample (except with respect to disease status) from
Finland, if we assume that different regions of Finland
have similar rates of the disease. The right panel of Figure 3
shows the ratio of the estimated effective size from the ALS
cohort to the census size of Finland at selected time points.
We chose to let the g¼ 0 generation correspond to the year
in which the average age of the sample was 25, that is, in
1969. We assumed a 30 year generation time, so that, for
example, the g ¼ 2 generation corresponded to 1909.
We expect that the effective size will be several times
smaller than census population sizes because of the inclu-
sion of children and elderly individuals in the census,
variance in reproduction rates, and other factors.25 Demo-
graphic arguments based on one modern human popula-
tion have suggested a ratio of effective size to census size
of around one-third.6 The ratio was 0.34 (95% confidence
interval ¼ 0.27–0.51) for the g ¼ 6 generation, 0.41 (95%
confidence interval ¼ 0.30–0.75) for the g ¼ 4 generation,
0.59 (95% confidence interval ¼ 0.38–1.15) for the g ¼ 2
generation, and 0.92 (95% confidence interval ¼ 0.52–
1.91) for the g ¼ 0 generation. Thus, the ratio matches
expectation for the higher generations (4 and 6) but is
too high for generation 0. It is likely that the effective
size was overestimated at generations 0 and 2 because of
the extrapolation of earlier growth rates to generations 0
and 1 and of the fitting of constant growth rates to groups
of eight generations, both of which ignore a reduction in
growth rates that occurred in the most recent generations.
Finland’s per-year population growth rate averaged 1.4%
between 1750 and 1850 (generations 4–7) but dropped to
0.9% between 1850 and 1950 (generations 1–4). Other fac-
tors, such as migration and changes in the variability of
reproduction rates between individuals, might also affect
the ratio.
The NFBC sample, being a birth cohort, should give a
good representation of Northern Finland as it was inJournal of Human Genetics 97, 404–418, September 3, 2015 409
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Figure 4. Effective Size of the of UK
Population
The threshold on IBD length is 2 cM for the
UK10K sequence data and 4 cM for the
WTCCC2 SNP array data. Estimated effec-
tive sizes are shown for 200 generations
for the UK10K sequence data (upper left
panel), whereas only 50 generations are
shown for the WTCCC2 data (upper right
panel) because they are derived from SNP
array data. Bootstrap 95% confidence inter-
vals are shown as shaded regions. The
lower left panel overlays the results for
the TWINSUK cohort with the results of
the full WTCCC2 data. The lower right
panel shows the ratio of estimated effective
size to census size (open circle) and boot-
strap 95% confidence intervals (vertical
lines). The effective sizes are from the
WTCCC2 analysis, and the census sizes
are for Great Britain (England, Wales, and
Scotland) for the years shown under the x
axis.1966. We compared the estimated effective size for the
g ¼ 0 generation to the census size of Northern Finland
(Lapland, Kainuu, and North Ostrobothnia; the latter
two regions compose the province of Oulu) in 1991,
when the cohort individuals were 25 years old. The esti-
mated effective population size for this generation was
380,000 (95% confidence interval ¼ 327,000–459,000),
whereas the census size was 648,000. This gives a ratio of
0.59 (95% confidence interval ¼ 0.50–0.71). As well as
the factors mentioned above for Finland as a whole, there
might be significant migration in and out of Northern
Finland, which would cause the effective size of this sam-
ple to represent more than just the individuals residing
in the region at a given point in time. When looking at
the effective population size in the more distance past,
one must keep in mind that these estimated sizes apply
to the ancestors of the current individuals, who include
immigrants from other regions, rather than to only the
population historically living in Northern Finland, which
might have had a lower effective population size.
United Kingdom
We analyzed two datasets from the United Kingdom (UK):
the UK10K sequence data and the Wellcome Trust Case
Control Consortium 2 (WTCCC2) control group. Both
datasets include only European-ancestry individuals living
in the UK.
The UK10K sequence data that we analyzed consist of
low-coverage sequence data on 1,927 individuals from410 The American Journal of Human Genetics 97, 404–418, September 3, 2015the Avon Longitudinal Study of Par-
ents and Children (ALSPAC) and
1,854 individuals from the TwinsUK
cohort. The ALSPAC individuals are
from the Bristol area, whereas the
TwinsUK individuals are from
throughout the UK. We downloadedthe genotype data from the European Genome-phenome
Archive (EGA) in April 2014 (release 20131101). We used
only diallelic single-nucleotide variants from the auto-
somes, excluded variants that weremonomorphic in either
of the two cohorts, excluded variants with a Hardy-Wein-
berg p value < 106 in either of the two cohorts, and
excluded variants with an average read depth of less than
2 per individual.
The WTCCC2 data that we analyzed consist of 5,200 in-
dividuals’ genotypes from a custom Illumina array with
approximately 1.2 million variants.26 The sample includes
2,699 individuals from the 1958 British Birth Cohort (58C)
and 2,501 individuals from the National Blood Service
(NBS) collection. All the individuals reside in Great Britain
(England, Wales, and Scotland). We downloaded the data
from the EGA in March 2011. We applied the WTCCC2
data-quality filters, which included removal of variants
with a minor allele frequency < 1%, missing propor-
tion > 2%, or Hardy-Weinberg p value < 1020.
Shown in Figure 4, estimated effective population sizes
for the UK10K and WTCCC2 data are based on IBD seg-
ments of length greater than 2 cM in the UK10K sequence
data and greater than 4 cM in the WTCCC2 SNP data. Re-
sults with a 3 cM threshold in the UK10K data and with a 3
or 5 cM threshold in the WTCCC2 data are similar (data
not shown). Computing times were 9 hr for the UK10K
data and 27 min for the WTCCC2 data.
The top left panel of Figure 4 shows estimated popula-
tion sizes for the past 200 generations from the two
UK10K samples, along with an estimate from the com-
bined UK10K set. The ALSPAC cohort had a lower effective
population size for the first 15 generations before the pre-
sent. This is due to the localized sampling of the ALSPAC
study in comparison to the nationwide sampling of the
TwinsUK study. The effective population size around
Bristol is less than that for the country as a whole because
of limited migration in and out of this region over short
time periods. The estimates for the combined UK10K
data are intermediate between the estimates for the
TwinsUK and ALSPAC cohorts.
The top right panel of Figure 4 shows the two WTCCC2
samples, along with an estimate from the combined
WTCCC2 set. Only 50 generations are shown, given that
the IBD was obtained from SNP array data. The concor-
dance between the three sets of estimates is excellent.
One of the remarkable aspects of this analysis is the high
degree of concordance between the estimates from the
TwinsUK and WTCCC2 datasets. The lower left panel of
Figure 4 shows estimates from TwinsUK against estimates
from WTCCC2 for the past 50 generations. The estimates
from these two samples are almost indistinguishable over
this range of generations, particularly for generations
1–20. In generations 20–50, the estimates diverge slightly,
such that the WTCCC2 estimates are lower because of the
greater uncertainty in estimated lengths of IBD segments
in the analysis of SNP data, as discussed above.
The confidence intervals for the combined WTCCC2
data are narrower than those for the TwinsUK cohort,
because the sample size is much larger, so we used the esti-
mates from the combined WTCCC2 in what follows. The
estimated effective size for the g ¼ 0 generation (for indi-
viduals born in or around 1958) is 27 million (95% confi-
dence interval ¼ 21–34 million). Because of extrapolation
in a population with slowing growth rates, this estimate
might be too high. As noted above with the Northern
Finland results, the census size is expected to be several
times larger than the effective population size. The lower
right panel of Figure 4 shows the ratio of effective size to
census size. A generation length of 30 years is assumed,
whereby generation 0 corresponds to 1981, when the
58C individuals were 23 years old (census figures for the
UK are provided at intervals of 10 years, so we could not
use the year when this cohort was 25). The census figures
include England, Wales, and Scotland (sources are AVision
of Britain through Time and the Office for National Statis-
tics UK; see Web Resources). The estimated ratio was 0.36
(95% confidence interval ¼ 0.34–0.42) for generation 6,
0.33 (95% confidence interval ¼ 0.29–0.39) for generation
4, 0.34 (95% confidence interval ¼ 0.28–0.41) for genera-
tion 2, and 0.49 (95% confidence interval ¼ 0.37–0.62)
for generation 0.
For comparison, we considered the UK results from
Ralph and Coop.14 Ralph and Coop’s estimates were based
on a smaller sample size (358 individuals from the UK). We
obtained their estimates from the beige ‘‘smooth’’ curve of
the top panel on page 81 of Figure S17 of their paper.The AmericanBecause the values are read from a figure rather than a
table, they are approximate. Their results are presented in
terms of the coalescence rate m(g) ¼ P(TMRCA ¼ g). As we
discuss in Appendix A,
PðTMRCA ¼ g j NÞ ¼ 1
2N½g
Yg1
g0¼1

1 1
2N½g 0

:
We can invert this to obtain
N½g ¼ 1
2mðgÞ
Yg1
g0¼1
ð1 mðg 0ÞÞ:
Because the estimated values of m(g) are small for the UK
(less than 105), we ignore the product term and use the
simpler inversionN[g]¼ 1/(2m(g)). We obtain the following
trajectory: the effective size was greater than 4 million
more than 3,900 years (130 generations) ago, dropped to
75,000 by 2,250 years (75 generations) ago, increased to
over 4 million 1,380 years (46 generations) ago and stayed
at over 4 million until 1,080 years (36 generations) ago,
dropped to 250,000 around 660 years (22 generations)
ago, and increased to stay at over 4 million for the most
recent 420 years (14 generations). This trajectory is signif-
icantly more oscillatory than our estimates shown in
Figure 4.Discussion
We have presented a non-parametric method for esti-
mating recent effective population size. In our analyses
of data from Northern Finland and from the UK, results
were consistent with the known history of these popula-
tions. In our analyses of simulated data, we found that
even complex population histories with super-exponential
growth rates can be estimated well. In contrast, the para-
metric approach implemented in the software DoRIS4 is
constrained by computational feasibility to consider only
simple parametric models with a handful of parameters,
limiting its ability to flexibly estimate effective population
size under complex population histories.
In our analyses, we used IBDseq16 to detect IBD seg-
ments. We verified through simulation that the IBD seg-
ments estimated with IBDseq result in accurate estimates
of effective population size, as long as a sufficiently large
length threshold is used on the IBD segments. The length
threshold needs to be sufficiently large so that almost all
actual IBD segments with a size exceeding the threshold
are detected. For sequence data, we found that a threshold
of 2 cM works well, whereas for SNP array data, a
threshold of 3–6 cM is appropriate, depending on the
SNP density. When SNP array data are used, uncertainty
about IBD-segment endpoints results in an excess of
segments exceeding the length threshold and hence an
underestimation of effective population size more than
50 generations in the past. Thus, using SNP data allows
one to estimate effective population sizes over the pastJournal of Human Genetics 97, 404–418, September 3, 2015 411
50 generations, or 1,500 years if the generation time is
30 years, with reasonable precision. With sequence data
and a 2 cM threshold, one can estimate effective popula-
tion sizes for the past 200 generations (6,000 years).
Unless the population is very small and the sample very
large, IBD data contain little information about the most
recent generation or two. For example, in a randommating
population of effective size ten million, the chance that a
randomly selected pair of individuals share a common
grandparent (i.e., a most recent common ancestor two gen-
erations ago) is approximately 42/107. Thus, in a sample of
1,000 individuals, which has approximately 0.5 million
pairs, one would expect 0.8 pairs of cousins, which is
clearly not enough to be informative about the g ¼ 2 gen-
eration. The chance that a randomly selected pair of
individuals share a common great-grandparent is approxi-
mately 82/107, so 3.2 pairs of second cousins would be
expected. Thus, it is difficult to estimate even the g¼ 3 gen-
eration in a population of this size, except by extrapolation
of growth rates from earlier generations. Our method fits
constant population growth over groups of eight genera-
tions, which enables estimation for the most recent gener-
ations if we assume that growth rates have stayed relatively
constant over time. However, many human populations
have undergone reductions in growth rates in the last
few generations, as population densities have increased
and birth-control methods have become more effective,
so estimates for the most recent couple of generations
should be interpreted with care.
IBD-segment data do not provide single-generation reso-
lution in the estimation of historical effective population
size because the probability distribution of the age of a
segment given its length and the historical effective popu-
lation size is quite wide. One consequence of this is that
the iterative estimation procedure has a tendency to
converge toward an oscillatory solution, in which the esti-
mated effective population size oscillates between overly
high and overly low. We were able to ameliorate this
behavior by modeling the population-size history with
piecewise exponential functions and by averaging results
from multiple random starts. However, we found that
some oscillatory behavior can still occur, particularly
when the sample size is low. Although the bootstrap confi-
dence intervals usually contain the true effective popula-
tion size, the shape of the estimated trajectory might
suggest growth-rate changes that are purely due to this arti-
factual oscillatory behavior. Thus, we caution against over-
interpretation of apparent changes in growth rates over
short timescales. An alternative approach to addressing
the oscillation issue would be to use a penalized likelihood
as in Ralph and Coop.14 However, examination of the esti-
mates of coalescence rates from Figures S16 and S17 of
Ralph and Coop’s paper indicates that their method gives
significantly higher levels of oscillation than ours, albeit
over longer timescales. Looking at the within-population
results, we see that in almost all instances, the estimated
coalescence rate increases significantly and then drops412 The American Journal of Human Genetics 97, 404–418, Septembback (equivalently, the effective population size decreases
substantially and then rises again) at least once across the
135 generations shown. Thus, the penalization approach
employed by Ralph and Coop does not seem to be an
adequate solution to the oscillation issue in the context
of estimating effective population size.
Our approach works directly with inferred IBD seg-
ments. In contrast, the method of Harris and Nielsen13
skips detection of IBD segments and instead works directly
with identical-by-state haplotypes as a proxy. A potential
advantage of that approach is that one can examine
shorter segments and hence look further back into the
past. A disadvantage is that high-quality phased sequence,
such as trio-phased high-coverage sequence data, is
required. In Harris and Nielsen’s analyses, they used only
one European trio (four parental haplotypes) and one Afri-
can trio. As with the ARG-based methods11 and SFS-based
methods,7 the ability of IBD-based methods to estimate
very recent effective population sizes is highly dependent
on the sample size. In our results, we saw this phenome-
non in the simulated data (200 versus 1,000 individuals)
and UK datasets (2,000 versus 5,000 individuals). Harris
and Nielsen did not infer changes in population size
within the past several thousand years, and their final
effective population size for Europeans was less than
20,000, whereas our estimate was over ten million for
the UK.
The ability of our method to infer very recent effective
population sizes is a major advantage over other methods.
In previous human-population studies using demographic
rather than genetic approaches, the ratio of effective
population size to census size varied between 0.21 and
0.65.27 However, many existing methods for estimating
effective population size from genetic data yield estimates
that are orders of magnitude smaller than the census size of
the population from which the sample was drawn. In
contrast, the ratio of our estimated effective population
size four generations ago to the corresponding census
size was 0.41 for Finland and 0.33 for the UK.
The sampled individuals are assumed to be a random
sample from the population of interest. Our method ap-
pears to be robust to small deviations from this assump-
tion. The UK NBS data might be somewhat non-random
because certain sub-populations might be more or less
likely to donate blood. Nonetheless, the NBS data gave
essentially the same results as the 58C data. Similarly, the
ALS sample from Finland is non-random with respect to
disease status but is sufficiently representative of Finland’s
population to give reasonable estimates. Although we
focused on human populations, our method is also
applicable to random samples from non-human diploid
populations.
IBDseq assumes population homogeneity16 so that pop-
ulation-average allele frequencies are applicable to all pairs
of individuals. Thus, we do not recommend the use of
IBDseq in samples with multiple continental ancestries,
including admixed populations. Other methods coulder 3, 2015
also be used for detecting the IBD segments that are used in
estimating the effective population size. We have found
that haplotype-based methods such as Refined IBD18 are
robust to admixture and other population heterogeneity
(data not shown). However, for application to this prob-
lem, it is important that such methods allow for genotype
error and haplotype phase error (if applicable) in order to
avoid splitting large IBD segments into smaller pieces.
For application of this method, one must have moder-
ately dense genome-wide genotype data for a random
sample of at least several hundred individuals. In our ana-
lyses of human populations, we successfully analyzed
three types of population samples: trait-based cohorts
(TWINSUK and ALS) for which the ascertainment strategy
uniformly covers the population of interest, birth cohorts
(NFBC and 58C), and a blood-bank cohort (NBS).Appendix A: Details of the Estimation Procedure
Estimated Amount of Inferred IBD from Generation g
Let N ¼ {N[g]; g ¼ 0, 1, 2 .} be the current estimate of
diploid effective population size (one-half of the effective
number of haplotypes) at each generation g before the cur-
rent generation. Let C be the minimum IBD-segment
length in cM, and let G be the maximum number of gener-
ations over which we will compute the effective popula-
tion size. G should be sufficiently large so that observing
an IBD segment of size> C cM is very small if the common
ancestor lived more than G generations ago. We will as-
sume N[g] ¼ N[G] for g > G. We also assume that all the
IBD segments are from generation g* or higher because of
removal of IBD segments from close relatives. In the re-
sults, we use g* ¼ 2.
We define an IBD segment as a shared haplotype
inherited identically by descent and unbroken by recombi-
nation. Consider a segment S, which is defined by its end-
points s1 and s2 and has an associated length l ¼ s2  s1,
measured in cM.
If the TMRCA of S is g, there are gmeioses from the most
recent common ancestor to each of the two IBD haplo-
types, and each meiosis has the potential for a crossover
that would end the IBD segment. The probability distribu-
tion for l depends on whether we have selected S at
random from a list of IBD segments discovered in the
analyzed region or whether we have selected S at random
from the set of IBD segments covering some specific posi-
tion in the analyzed region. In the former instance, if we
assume Haldane’s model for crossovers at each meiosis
and assume that crossovers occur independently at each
meiosis with rate 1/100 per cM, the distribution of l on a
chromosome of infinite length is exponential with rate
2g/100 ¼ g/50 per cM. In the latter instance, where S is
selected from IBD segments covering some specific posi-
tion on the chromosome, the distribution is different.
Random longer segments are more likely than random
shorter segments to cover the specified position; thus,The Americanthe expected value of l is higher. If we assume Haldane’s
model again, on a chromosome of infinite length, the dis-
tribution of the l of S on each side of the specified position
is exponential with rate g/50 per cM, and thus the total l is
Erlang with rate g/50 per cM and shape 2.4
We can also calculate the probability of IBD at a specified
position for a randomly chosen pair of haplotypes. Under
the Wright-Fisher model, the probability that two haplo-
types sampled from the current population have a TMRCA
of one generation is 1/(2N[1]). To see this, condition on the
parental haplotype inherited by the first sampled haplo-
type. The parental haplotype inherited by the second
sampled haplotype is chosen at random from the 2N[1]
haplotypes in the population at generation 1. Similarly,
the probability that two haplotypes sampled from the cur-
rent population have a TMRCA of two generations is the
product of the probability that they don’t have a TMRCA
of one generation and the probability that the two in-
herited parental haplotypes at generation 1 are inherited
from a common grandparental haplotype at generation 2.
Taking this further, the probability of a TMRCA of g gener-
ations is4
PðTMRCA ¼ g j NÞ ¼ 1
2N½g
Yg1
g0¼1

1 1
2N½g 0

:
Because we don’t estimate N[g] for g < g*, we assume that
N[g] is large enough so that 1  1/(2N[g]) is approximately
equal to 1 for g < g*. Then,
PðTMRCA ¼ g j NÞ ¼ 1
2N½g
Yg1
g 0¼g

1 1
2N½g 0

:
Equation A1
Thus, given a segment Swith endpoints s1 and s2, we can
calculate the distribution of its TMRCA by using Bayes rule:
PðTMRCA ¼ g j s1; s2;NÞ
¼ Pðs1; s2 jTMRCA ¼ g;NÞPðTMRCA ¼ g j NÞ
Pðs1; s2 j NÞ :
Equation A2
The distribution P(s1, s2 j TMRCA ¼ g, N) depends on
whether the IBD segment reaches the ends of the chromo-
some. We show how to calculate this probability below.
The amount of IBD from S that can be attributed to a
TMCRA of g generations is then
ðs2  s1ÞPðTMRCA ¼ g j s1; s2; NÞ:
If we index IBD segments by j and sum over all IBD seg-
ments with length l ¼ (s2  s1) greater than the threshold
C, the total amount of IBD attributable to a TMRCA of g isX
j
lðjÞ PðTMRCA ¼ g j s1ðjÞ; s2ðjÞ;NÞ: Equation A3
Below, we provide equations for the amount of an IBD
segment attributable to each TMRCA while conditioningJournal of Human Genetics 97, 404–418, September 3, 2015 413
on the observed length of the segment and the number of
segment ends that reach the end of the chromosome.
When probabilistically allocating an IBD segment to
each TMRCA, it is helpful to consider a specific point h
on the chromosome. We first consider an observed IBD
segment S that covers position h and that is interior to
the chromosome (0 < s1 < h < s2 < L).
We want to estimate the probability that the most
recent common ancestor corresponding to our IBD
segment is at generation g (i.e., TMRCA ¼ g), given that
the segment with observed endpoints s1 and s2 is
randomly chosen from segments covering h. Condition-
ing on the TMRCA and the fact that the segment covers
h, we can consider s1 and s2 to be random variables. Simi-
larly, conditioning on the observed segment endpoints,
we can consider the TMRCA to be a random variable.
With Equation A2,
PðTMRCA ¼ g j s1; s2;h;NÞ
fPðs1; s2 jTMRCA ¼ g;h;NÞ
3PðTMRCA ¼ g jh;NÞ
¼ Pðs1 jTMRCA ¼ g;h; s1 < hÞ
3Pðs2 jTMRCA ¼ g;h; s2 > hÞ
3PðTMRCA ¼ g jNÞ:
In the above equation, probability densities and discrete
probabilities are both represented by P, and the symbol f
means ‘‘is proportional to.’’
Conditional on TMRCA ¼ g, h  s1 is distributed expo-
nentially with rate 2g/100 ¼ g/50 per cM, and thus
Pðs1 j TMRCA ¼ g;h; s1 < hÞ ¼ expð ðh s1Þg=50Þðg=50Þ:
Similarly,
Pðs2 j TMRCA ¼ g;h; s2 > hÞ ¼ expð ðs2  hÞg=50Þðg=50Þ:
Thus,
Pðs1 jTMRCA ¼ g;h; s1 < hÞPðs2 jTMRCA ¼ g;h; s2 > hÞ
¼
 g
50

exp

 ðh s1Þg
50
 g
50

3 exp
ðs2  hÞg
50

¼
 g
50
2
exp

 ðs2  s1Þg
50

¼
 g
50
2
exp

 lg
50

:
Note that this probability does not depend on the partic-
ular value of h.
Using the distribution of the TMRCA from Equation A1,
we have
PðTMRCA ¼ g j l; h;N ;0 < s1 < h < s2 < LÞ ¼ 1
g0ðl;NÞ
3
 g
50
2
exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g;414 The American Journal of Human Genetics 97, 404–418, Septembwhere the constant of proportionality g0ðl;NÞ is
g0ðl;NÞ ¼
XN
g¼g
 g
50
2
exp

 lg
50
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2N½g
¼
XG
g¼g
 g
50
2
exp

 lg
50

3
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g þ
XN
g¼Gþ1
 g
50
2
3 exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g:
The left summand can be calculated directly. If G is
sufficiently large, the right summand is approximately 0.However, because N[g] ¼ N[G] for g R G, the right sum-
mand has a closed-form solution. If we let a ¼ l/50 and
b ¼ 1 1/(2N[G]), the right summand is
PN
g¼Gþ1
 g
50
2
exp

 lg
50
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2N½g
¼ PN
g¼Gþ1
g2ð1 bÞeag
2500
 Yg1
g0¼g

1 1
2N½g 0
!
¼
 YG
g0¼g

1 1
2N½g 0
! ð1 bÞeaðGþ1Þ
2500
3
PN
g¼Gþ1
g2eaðgG1ÞbgG1
¼
 YG
g0¼g

1 1
2N½g 0
! ð1 bÞeaðGþ1Þ
2500
3
PN
j¼0
ðjþ Gþ 1Þ2bea	j
¼
 YG
g0¼g

1 1
2N½g 0
! ð1 bÞeaðGþ1Þ
2500
3
PN
j¼0
ðG2 þ ð2G 1Þðjþ 1Þ þ ðjþ 1Þðjþ 2Þ	bea	j
¼
 YG
g0¼g

1 1
2N½g 0
! ð1 bÞeaðGþ1Þ
2500
3
 
G2
1 bea þ
2G 1
1 bea	2 þ 21 bea	3
!
:
The last step uses the equalities
PN
j¼0r
j ¼ 1=ð1 rÞ,PN
j¼0ðjþ 1Þrj ¼ 1=ð1 rÞ2, and
PN
j¼0ðjþ 1Þðjþ 2Þrj ¼
2=ð1 rÞ3, which hold for 0 < r < 1.
Thus,
g0ðl;NÞ ¼
XG
g¼g
 g
50
2
exp

 lg
50
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2N½g
þ
 YG
g0¼g

1 1
2N½g 0
! ð1 bÞeaðGþ1Þ
2500
3
 
G2
1 bea þ
2G 1
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2
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!
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Similarly, we can consider a segment that is truncated by
one end of the chromosome. Again, write s1 and s2 for the
positions of the endpoints of the segments, but now either
s1 ¼ 0 or s2 ¼ L. For concreteness, assume s1 ¼ 0. Our proba-
bility distributions for the lengthof the IBD segment assume
a chromosome of infinite length. Conceptually, we can ima-
gine that we do have a chromosome of infinite length and
that on this chromosome, the true IBD segment has left
endpoint s01%0.Because theanalyzed regiondoesn’t include
thepositions to the leftof0,wedonotobserve s01, but the fact
that s1 ¼ 0 implies that s01%0. Thus, we can calculate
PðTMRCA ¼ g j s1; s2;h;N;0 ¼ s1 < h < s2 < LÞ
¼ PTMRCA ¼ g j s01%0; s2;h;N	
fP

s01%0 jTMRCA ¼ g;h
	
Pðs2 jTMRCA ¼ g;hÞ
3PðTMRCA ¼ g jNÞ
¼ Ph s01	Rh jTMRCA ¼ g;h	
3Pðs2 jTMRCA ¼ g;hÞ
3PðTMRCA ¼ g jNÞ
¼ exp

hg
50

 g
50

3 exp

 ðs2  hÞg
50

PðTMRCA ¼ g jNÞ
¼
 g
50

exp

 ðs2  s1Þg
50

PðTMRCA ¼ g jNÞ
¼
 g
50

exp

 lg
50

PðTMRCA ¼ g jNÞ:
Thus,
PðTMRCA ¼ g j l;h;N;0 ¼ s1 < h < s2 < LÞ
¼ 1
g1ðl;NÞ
 g
50

exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g;
where
g1ðl;NÞ ¼
XG
g¼g
 g
50

exp

 lg
50
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2N½g
þ
XN
g¼Gþ1
 g
50

exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g:
As for g0, the left summand can be calculated directly,
and because N[g] ¼ N[G] for g R G, there is a closed form
for the right summand. Letting a ¼ l/50 and b ¼ 1  1/
(2N[G]), one can show (similarly as for g0) that
g1ðl;NÞ ¼
XG
g¼g
 g
50

exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g
þ
 YG
g 0¼g

1 1
2N½g 0
! ð1 bÞeaðGþ1Þ
50
3
 
G
1 bea þ
1
ð1 beaÞ2
!
:
The same formula holds for P(TMRCA ¼ g j l, h, N, 0 < s1 <
h < s2 ¼ L) when the right end point of the IBD segment is
censored by the end of the chromosome.The AmericanSimilarly, if the IBD segment covers the whole region
and is thus censored at both ends (s1 ¼ 0 and s2 ¼ L), we
consider the conceptual uncensored end points s01 < 0
and s02 > L to calculate the following:
PðTMRCA ¼ g j s1; s2;h;NÞ
¼ Ps01 < 0; s02 > L jTMRCA ¼ g;h	
¼ expðhg=50Þexpð  ðL hÞg=50Þ
¼ exp

Lg
50

¼ exp

 lg
50

:
Thus,
PðTMRCA ¼ g j l ¼ L;h;NÞ ¼ 1
g2ðl;NÞ
exp

 lg
50

3
 Yg1
g0¼1

1 1
2N½g 0
!
1
2N½g;
where
g2ðl;NÞ ¼
XG
g¼g
exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g
þ
XN
g¼Gþ1
exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g:
As for g0 and g1, the left summand can be calculated
directly, and because N[g] ¼ N[G] for g R G, there is a
closed form for the right summand. Letting a ¼ l/50 and
b ¼ 1  1/(2N[G]), one can show (similarly as for g0) that
g2ðl;NÞ ¼
XG
g¼g
exp

 lg
50
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g
þ
 YG
g0¼g

1 1
2N½g 0
! ð1 bÞeaðGþ1Þ
1 bea :
Binning by IBD Length to Reduce Computation Time
The probabilistic assignment of segments to TMRCAs de-
pends only on the length l ¼ s2  s1 of the segment and
the number of segment ends that reach the end of the
chromosome. In our analyses, we binned the observed
IBD segments by their length and number of ends reaching
the end of the chromosome and calculated P(TMRCA ¼ g j
l, N) only once for each bin. We used bins with a length
range of 0.05 cM, and we used the midpoint of the range
as the length in our calculation.
Expected Amount of IBD from Generation g
We also need to calculate the expected amount of IBD due
to most recent common ancestry g generations ago as a
function of N. The probabilities in this section do not con-
dition on data, but they do assume that historical effective
population sizes are known for each generation before the
present.
Let nP be the number of pairs of haplotypes considered.
If the sample of interest contains nI diploid individuals,Journal of Human Genetics 97, 404–418, September 3, 2015 415
then the number of pairs of haplotypes where each haplo-
type is from a different individual is nP ¼ (2nI)(2nI  2)/2.
We consider pairs of distinct individuals because we are
not considering homozygosity by descent (IBD between
the two haplotypes within an individual).
If we consider an IBD segment covering a certain posi-
tion on a chromosome of infinite length, as noted above,
the length, l, of the segment is Erlang with rate g/50 and
shape 2. Thus,
Pðl > C jTMRCA ¼ gÞ ¼

Cg
50
þ 1

eCg=50
and
Pðl > C;TMRCA ¼ gÞ
¼ PðTMRCA ¼ gÞPðl > C j TMRCA ¼ gÞ
¼ 1
2N½g
 Yg1
g0¼g

1 1
2N½g 0
!
3

Cg
50
þ 1

eCg=50:
If we integrate over all positions on an analyzed chromo-
some with length L cM and consider IBD from nP pairs of
haplotypes, the expected amount of IBD of length > C
cM with TMRCA ¼ g is
nPL Pðl > C;TMRCA ¼ gÞ ¼ nPL 1
2N½g
 Yg1
g 0¼g

1 1
2N½g 0
!
3

Cg
50
þ 1

eCg=50:
Equation A4
Segments that occur at the ends of the analyzed chromo-
somes might be censored by the chromosome end, and
thus the observed length might not meet the length
threshold. For censoring at the left end of the chromo-
some, consider focal position h < C, and consider an IBD
segment containing h with right end point s2 < C (and
thus with observed length < C cM). The probability that
the segment has conceptual end point s01 < s2  C (and
thus with conceptual length > C cM) is
P

s01 < s2  C j s01 < h < s2
	 ¼ Ph s01 > h s2 þ C	
¼ eðhs2þCÞg=50:
Thus, the probability that an IBD segment containing
h has right end point s2 < C (observed length < C) and
conceptual left end point s01 < s2  C (conceptual
length > C cM) is
ZC
h
Pðs2ÞP

s01 < s2  C
	
ds2 ¼
ZC
h
g
50
eðs2hÞg=50eðhs2þCÞg=50ds2
¼
ZC
h
g
50
eCg=50ds2 ¼ ðC hÞ g
50
eCg=50:416 The American Journal of Human Genetics 97, 404–418, SeptembIntegrating this over values of h < C and multiplying
by the probability of IBD with TMRCA ¼ g and by the
number of pairs of haplotypes allow us to determine
how much IBD in the region needs to subtracted from
the total given in Equation A4. The amount to be sub-
tracted as a result of censoring at this end of the chromo-
some is thus
nP
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2N½g
ZC
0
ðC hÞ g
50
eCg=50dh
¼ nP
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½g
C2g
100
eCg=50:
Doubling this to account for both ends of the region and
subtracting from the expected amount of IBD when
endpoint censoring is ignored in Equation A4, we obtain
the following expectation for the amount of IBD with
TMRCA ¼ g and observed length > C cM on a single chro-
mosome of length L:
nP
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2N½g

Cg
50
þ 1

L C
2g
50

eCg=50:
We obtain the expected amount of IBD with TMRCA of
g generations from K chromosomes of lengths Lk (k ¼ 1,
2, ., K) by summing the expected amounts from each
chromosome:
nP
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½ge
Cg=50
3
XK
k¼1

Cg
50
þ 1

Lk  C
2g
50

:
Equation A5
Updating the Estimate of Historical Effective
Population Size N[g]
We first show how to update the estimate of N[g]
without the constraint of a piecewise exponential
trajectory. By considering fN½g 0 : g 0 ¼ g;.; g  1g to
be fixed at their previous estimated values, we can
equate the expected and observed values obtained
from Equations A3 and A5 and solve for N[g]. That is,
we solve
X
j
lðjÞPðTMRCA ¼ g j s1ðjÞ; s2ðjÞ;NÞ
¼ nP
 Yg1
g0¼g

1 1
2N½g 0
!
1
2N½ge
Cg=50
3
XK
k¼1

Cg
50
þ 1

Lk  C
2g
50

to estimate N[g] in terms of N½g; N½g þ 1; .;
N½g  1 byer 3, 2015
bN ½g ¼ np
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2
eCg=50
XK
k¼1

Cg
50
þ 1

Lk  C
2g
50

P
j
lðjÞPðTMRCA ¼ g j s1ðjÞ; s2ðjÞ;NÞ ; Equation A6where the sum over j is over the observed IBD segments
S(j) with length l(j) ¼ s2(j)  s1(j) > C cM.
We now describe how to do the estimation when
imposing the piecewise exponential constraint. First, we
divide the range of considered generations, g* % g % G,
into intervals. We take the first interval to have length
4 þ x, where x is uniformly distributed on 1, 2, ., 8.
Thus, the first interval is g*% g% (g* þ 3 þ x). Except for
the first and last intervals, the intervals have length 8, so
the second interval is (g* þ 4 þ x) % g % (g* þ 11 þ x),
and so on. The final interval has a length between 1
and 8. The uniformly distributed value x is generated inde-
pendently for each iteration and each random start.
Write
Xg ¼
X
j
lðjÞPðTMRCA ¼ g j s1ðjÞ; s2ðjÞ;NÞ;
which is the amount of observed IBD assigned to genera-
tion g (see Equation A3), and write
Yg ¼ np
 Yg1
g 0¼g

1 1
2N½g 0
!
1
2
eCg=50
3
XK
k¼1

Cg
50
þ 1

Lk  C
2g
50

;
which is the product of N[g] and the expected amount of
IBD from generation g (see Equation A5).
First, we calculate a constant N for the final interval of
generations, gz % g % G. This is obtained asXG
g¼gz
Yg
XG
g¼gz
Xg :
Next, we work our way from the high values of g toward
the low values. If the interval is g1% g% g2, we fit an expo-
nential growth curve of the following form:
N½g ¼ N½g2 þ 1erðg2þ1gÞ: Equation A7
To fit this, consider the following function:
f ðrÞ ¼
Xg2
g¼g1
Xg 
Xg2
g¼g1
Yg
N½g ¼
Xg2
g¼g1
Xg 
Xg2
g¼g1
Yge
rðgg21Þ
N½g2 þ 1 :
That is, f is a function of the growth rate that takes value
0 when the observed and expected IBD (summed over
the range of generations g1 % g % g2) are equal.
We solve for r by using Newton’s method: we start from
an initial value of r ¼ 0 and iterate until the difference inThe Americansuccessive values of r is less than 0.001. Once the value
of r is determined, the values of N[g2], N[g2  1], ., N[g1]
are obtained with Equation A7.
In some cases, Newton’s method fails to converge or
takes too long to converge. If the number of iterations ex-
ceeds 100 or jrj> 2, we calculateN[g] individually for each g
in the interval by using Equation A6.Supplemental Data
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